$3,742.63 travel Payment -- Roche/Genentech to Dr. Michelle Scott

Roche/Genentech Pays Over $3,700 for Travel to Ophthalmologist Michelle Scott

This page provides a detailed analysis of a $3,742.63 travel payment from Roche/Genentech to Dr. Michelle Scott. Data is from the CMS Open Payments (Sunshine Act) database.

Payment Details

FieldValue
Amount$3,742.63
Payment Typetravel
Payment NatureTravel and Lodging
Pharmaceutical CompanyRoche/Genentech
PhysicianDr. Michelle Scott
NPI Number1897811057
Physician SpecialtyOphthalmology
LocationLowell, MA
Date of Payment2025-12-19
Related Drug/DeviceEntresto
Conflict AssessmentModerate -- Worth Noting

AI-Powered Analysis of This Payment

The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.

Roche/Genentech made a $3.7K travel payment to Michelle Scott, a Ophthalmology specialist in Lowell, MA. The payment was associated with Entresto. The payment of $3,742.63 to Dr. Michelle Scott from Roche/Genentech for travel and lodging related to Entresto is a significant amount for a single trip. This payment occurred in late 2025, indicating ongoing engagement between the pharmaceutical company and the physician. The payment was for travel and lodging, suggesting it was likely related to a conference, training, or educational event.

Patient Guidance: What This Payment Means for You

If you received travel payments from a drug company, ensure it was for legitimate educational purposes and not to influence your prescribing habits. Always discuss your treatment options with your healthcare provider and ask about alternatives.

Payment Context: Is This Amount Normal?

While travel payments are common, the amount of $3,742.63 for a single instance of travel and lodging is on the higher end for many specialties, including Ophthalmology, and suggests a potentially significant event or duration.

Regulatory Context: Sunshine Act Requirements

Payments for travel and lodging must be directly related to the provision of goods or services, such as attending a conference or training, and must be reported under the Sunshine Act.

Related Topics

This payment is related to the following healthcare transparency topics:

Understanding travel Payments

Travel and lodging payments cover transportation and accommodation expenses for physicians attending conferences, advisory board meetings, or speaking engagements sponsored by pharmaceutical companies. These payments can be substantial, particularly for international travel or multi-day events.

Frequently Asked Questions About This Payment

What was this $3.7K payment for?

This was a travel payment of $3.7K from Roche/Genentech to Michelle Scott, categorized as "Travel and Lodging". It was associated with Entresto. The payment was reported under the Sunshine Act (CMS Open Payments).

Does Michelle Scott accept pharmaceutical money?

Yes, Michelle Scott received this $3.7K payment from Roche/Genentech. Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view Michelle Scott's full payment history on the CMS Open Payments database or on this site.

Is it legal for doctors to accept pharma payments?

Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.

Should I be concerned about this travel payment?

A travel payment of $3.7K should be evaluated in context. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.

How do I talk to my doctor about pharma relationships?

You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.

What types of pharma payments are most concerning?

Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.

Does pharma money affect what my doctor prescribes?

Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.

How does this compare to other doctors in Ophthalmology?

To compare this payment against Ophthalmology averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Ophthalmology physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.

What does this payment reveal about Michelle Scott's relationship with Roche/Genentech?

The payment amount is substantial for travel and lodging, warranting further investigation into the nature of the event. This $3.7K travel payment is part of the transparency data reported under the Sunshine Act.

Is this payment amount typical for Ophthalmology?

The specific drug mentioned, Entresto, is a cardiovascular medication, which might be relevant to ophthalmology if there are related ocular conditions.

What should patients do after learning about this payment?

If you received travel payments from a drug company, ensure it was for legitimate educational purposes and not to influence your prescribing habits.

What else should I know about this travel payment?

The payment date is in the future, which is unusual for CMS Open Payments data and may indicate a data entry error or a pre-scheduled event.

Related Reports

Data from CMS Open Payments. Payment does not imply wrongdoing. Consult your healthcare provider about any concerns.